Inventor
OLSEN DAVID B
US40 patents
⚠️ This page may combine multiple inventors who share the name “OLSEN DAVID B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
11 patentsUS7323449B2Jan 29, 2008
Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
MERCK & CO INC58 citations98
US7125855B2Oct 24, 2006
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
MERCK & CO INC301 citations98
US6777395B2Aug 17, 2004
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus
MERCK & CO INC356 citations98
US5861501AJan 19, 1999
Capped synthetic RNA, analogs, and aptamers
MERCK & CO INC115 citations98
US7470664B2Dec 30, 2008
HCV NS3 protease inhibitors
MERCK & CO INC81 citations97
US7323453B2Jan 29, 2008
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
MERCK & CO INC71 citations97
US7632821B2Dec 15, 2009
Ribonucleoside cyclic acetal derivatives for the treatment of RNA-dependent RNA viral infection
MERCK & CO INC67 citations95
US6111095AAug 29, 2000
Capped synthetic RNA, analogs, and aptamers
MERCK & CO INC76 citations95
US6369208B1Apr 9, 2002
Capped synthetic RNA, analogs, and aptamers
MERCK & CO INC32 citations92
US6100028AAug 8, 2000
DNA polymerase extension assay
MERCK & CO INC16 citations83
US5660989AAug 26, 1997
DNA polymerase extension assay for influenza virus endonuclease
MERCK & CO INC5 citations62
MERCK SHARP & DOHME
6 patentsUS7879815B2Feb 1, 2011
Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
MERCK SHARP & DOHME132 citations96
US9777035B2Oct 3, 2017
4′-substituted nucleoside reverse transcriptase inhibitors
MERCK SHARP & DOHME10 citations81
US10947205B2Mar 16, 2021
Oxazolidinone compounds and methods of use thereof as antibacterial agents
MERCK SHARP & DOHME5 citations70
US9765107B2Sep 19, 2017
Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
MERCK SHARP & DOHME1 citations51
US10144741B2Dec 4, 2018
Nargenicin compounds and uses thereof as antibacterial agents
MERCK SHARP & DOHME0 citations50
US9944654B2Apr 17, 2018
Nargenicin compounds and uses thereof as antibacterial agents
MERCK SHARP & DOHME0 citations50
MERCK SHARP & DOHME LLC
5 patentsUS12338219B2Jun 24, 2025
Antimalarial agents
MERCK SHARP & DOHME LLC1 citations61
US12435077B2Oct 7, 2025
Oxazolidinone compound and methods of use thereof as an antibacterial agent
MERCK SHARP & DOHME LLC0 citations59
US12350270B2Jul 8, 2025
Antimalarial agents
MERCK SHARP & DOHME LLC1 citations57
US11766435B2Sep 26, 2023
N3-substituted iminopyrimidinones as antimalarial agents
MERCK SHARP & DOHME LLC0 citations53
US12365656B2Jul 22, 2025
Oxazolidinone compounds and methods of use thereof as antibacterial agents
MERCK SHARP & DOHME LLC0 citations46
MAX PLANCK GESELLSCHAFT
3 patentsGIRIJAVALLABHAN VINAY
3 patentsUS9061041B2Jun 23, 2015
2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
GIRIJAVALLABHAN VINAY49 citations93
US9156872B2Oct 13, 2015
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
GIRIJAVALLABHAN VINAY45 citations92
US9150603B2Oct 6, 2015
2′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases
GIRIJAVALLABHAN VINAY14 citations82
MINNESOTA MINING & MFG
3 patentsUS4444247AApr 24, 1984
Filter-conditioner for motor cooling liquid
MINNESOTA MINING & MFG20 citations80
US4995452AFeb 26, 1991
Filter-conditioner for motor cooling liquid
MINNESOTA MINING & MFG10 citations71
US4018605AApr 19, 1977
Metal lithographic plate made imageable by diffusion transfer by treatment with Group IV-B metal fluoride
MINNESOTA MINING & MFG3 citations63